U.S. flag

An official website of the United States government

NM_000136.3(FANCC):c.1561G>A (p.Glu521Lys) AND Fanconi anemia

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Aug 21, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000706885.16

Allele description [Variation Report for NM_000136.3(FANCC):c.1561G>A (p.Glu521Lys)]

NM_000136.3(FANCC):c.1561G>A (p.Glu521Lys)

Genes:
FANCC:FA complementation group C [Gene - OMIM - HGNC]
AOPEP:aminopeptidase O (putative) [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
9q22.32
Genomic location:
Preferred name:
NM_000136.3(FANCC):c.1561G>A (p.Glu521Lys)
HGVS:
  • NC_000009.12:g.95101823C>T
  • NG_011707.1:g.220887G>A
  • NG_027833.2:g.380126C>T
  • NG_116860.1:g.265C>T
  • NM_000136.3:c.1561G>AMANE SELECT
  • NM_001243743.2:c.1561G>A
  • NP_000127.2:p.Glu521Lys
  • NP_000127.2:p.Glu521Lys
  • NP_001230672.1:p.Glu521Lys
  • LRG_497t1:c.1561G>A
  • LRG_497:g.220887G>A
  • LRG_497p1:p.Glu521Lys
  • NC_000009.11:g.97864105C>T
  • NM_000136.2:c.1561G>A
  • NM_001243744.1:c.*9373G>A
Protein change:
E521K
Links:
dbSNP: rs752855423
NCBI 1000 Genomes Browser:
rs752855423
Molecular consequence:
  • NM_000136.3:c.1561G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001243743.2:c.1561G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Fanconi anemia (FA)
Synonyms:
Fanconi pancytopenia; Fanconi's anemia
Identifiers:
MONDO: MONDO:0019391; MeSH: D005199; MedGen: C0015625; Orphanet: 84; OMIM: PS227650

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000835959Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Aug 21, 2022)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

SCV002081134Natera, Inc.
no assertion criteria provided
Uncertain significance
(Aug 12, 2018)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Insight into genetic susceptibility to male breast cancer by multigene panel testing: Results from a multicenter study in Italy.

Rizzolo P, Zelli V, Silvestri V, Valentini V, Zanna I, Bianchi S, Masala G, Spinelli AM, Tibiletti MG, Russo A, Varesco L, Giannini G, Capalbo C, Calistri D, Cortesi L, Viel A, Bonanni B, Azzollini J, Manoukian S, Montagna M, Peterlongo P, Radice P, et al.

Int J Cancer. 2019 Jul 15;145(2):390-400. doi: 10.1002/ijc.32106. Epub 2019 Jan 24. Erratum in: Int J Cancer. 2020 Jul 15;147(2):E2. doi: 10.1002/ijc.32944.

PubMed [citation]
PMID:
30613976

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000835959.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 521 of the FANCC protein (p.Glu521Lys). This variant is present in population databases (rs752855423, gnomAD 0.008%). This missense change has been observed in individual(s) with breast cancer (PMID: 30613976). ClinVar contains an entry for this variant (Variation ID: 234512). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Natera, Inc., SCV002081134.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024